UNS 0.00% 0.5¢ unilife corporation

from annual report

  1. 10,259 Posts.
    lightbulb Created with Sketch. 12

    At the present time, although some of our customers have approved therapies, none of our customers has
    received or applied for regulatory clearance or approval from the FDA or a foreign regulatory authority for the
    commercial sale of a drug-device combination product that incorporates any of our products. As such, although
 
watchlist Created with Sketch. Add UNS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.